about
Smoldering multiple myeloma.Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations.Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy.Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer.Monoclonal gammopathies of undetermined significance: a review.Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma.Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance.Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management.The Belgian 2010 consensus recommendations for the treatment of multiple myeloma.New approaches to smoldering myeloma.Management of asymptomatic myeloma patients.Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion.Thalidomide as initial therapy for early-stage myeloma.Unfolded protein response inducers tunicamycin and dithiothreitol promote myeloma cell differentiation mediated by XBP-1.Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts.Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.Multiple Myeloma: Diagnosis and Treatment.Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management
P2860
Q28082855-04D9F046-AA36-4EDD-A453-6EF1D351EBE3Q33628815-7A49A31C-402D-415F-9DA7-CCE95822B0CFQ33973877-F4892991-098E-4412-A66D-2C3E8489C6C0Q34557651-9A4B8212-B2D1-4FEC-9821-13C267672FA0Q35170927-0D9FA56F-0B6A-4525-AE0E-53F8C668774FQ36295077-F5DF5BCD-6F0D-4868-A69E-AB676B2C0CD7Q36449518-FBB3D4F0-EEA9-4478-9336-E4A5325BCD0EQ37623809-49299DA2-FDB2-48BA-856D-74CFCAFBCB68Q37800884-69E95D83-CC5A-4CE9-8BA6-EC78528A4A35Q38131457-B0FCD361-6D8E-4A03-8447-6A85437933CDQ38264322-C0181F66-006A-48C5-9EDC-1AB518A42EAEQ39689809-3C4FBC09-1D36-44FF-989B-8DC35C0D515EQ44394897-F46A9F97-1C94-4EEB-9170-4D62A3EB92C9Q44522462-901425AB-43F5-4E44-802E-CAFBBC080CADQ44857535-0B720D56-9143-4F1F-9A49-8BE652ACE91AQ46238706-DBCAEB35-FCA9-41EF-9848-4479697D8A94Q50233866-213FFC37-6F71-4C67-A9C4-EB94217ACF79Q55119496-48AAA77E-DDC4-4CA0-9ABC-299B4804552CQ58565204-BF3A51FA-8B7A-49FF-A6BE-D84B65747EF5
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A prognostic index for multiple myeloma.
@ast
A prognostic index for multiple myeloma.
@en
type
label
A prognostic index for multiple myeloma.
@ast
A prognostic index for multiple myeloma.
@en
prefLabel
A prognostic index for multiple myeloma.
@ast
A prognostic index for multiple myeloma.
@en
P2093
P2860
P356
P1476
A prognostic index for multiple myeloma.
@en
P2093
Brugnatelli S
Formisano R
Grignani G
Pieresca C
Riccardi A
P2860
P2888
P304
P356
10.1038/BJC.1996.212
P407
P577
1996-05-01T00:00:00Z
P5875
P6179
1027628336